Publications by authors named "Amanda Yuan-Ling Lim"
Article Synopsis
- Primary diabetes care and diabetic retinopathy (DR) screening face challenges due to a lack of trained primary care physicians, especially in low-resource areas.
- The integrated image-language system, DeepDR-LLM, combines a language model and deep learning to help PCPs provide tailored diabetes management recommendations, showing comparable or better accuracy than PCPs in diagnosing DR.
- In a study, patients assisted by DeepDR-LLM demonstrated improved self-management and adherence to referral recommendations, indicating that the system enhances both care quality and patient outcomes.
EndoBridge 2023 took place on October 20-22, 2023, in Antalya, Turkey. Accredited by the European Council, the 3-day scientific program of the 11 Annual Meeting of EndoBridge included state-of-the-art lectures and interactive small group discussion sessions incorporating interesting and challenging clinical cases led by globally recognized leaders in the field and was well attended by a highly diverse audience. Following its established format over the years, the program provided a comprehensive update across all aspects of endocrinology and metabolism, including topics in pituitary, thyroid, bone, and adrenal disorders, neuroendocrine tumors, diabetes mellitus, obesity, nutrition, and lipid disorders.
View Article and Find Full Text PDFObesity is a disease with a major negative impact on human health. However, people with obesity may not perceive their weight to be a significant problem and less than half of patients with obesity are advised by their physicians to lose weight. The purpose of this review is to highlight the importance of managing overweight and obesity by discussing the adverse consequences and impact of obesity.
View Article and Find Full Text PDFArticle Synopsis
- A meta-analysis was conducted to evaluate the weight loss effects of SGLT2 inhibitors and the combined SGLT1/SGLT2 inhibitors, using data from various trials published over two decades.
- The analysis included 116 randomized-controlled trials with nearly 100,000 patients, revealing an average weight loss of -1.79 kg and a BMI change of -0.71 kg/m compared to placebo.
- The study found that SGLT1/SGLT2 inhibitors were more effective for weight reduction than SGLT2 inhibitors alone, highlighting their potential in weight management, though more research is needed.
Objective: Non-alcoholic fatty liver disease is highly prevalent in patients with type 2 diabetes mellitus. Studies on glucagon-like peptide-1 receptor agonists for the treatment of non-alcoholic fatty liver disease have reported promising results. Despite this, there has been limited evidence of its efficacy in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus.
View Article and Find Full Text PDFObjective: Non-alcoholic fatty liver disease (NAFLD) is a very common disorder among patients with type 2 diabetes and may share causal relationship. Type 2 diabetes is a risk factor for progression and potential poor outcomes in NAFLD patients. This meta-analysis aimed to analyze the current evidence of sodium-glucose co-transporter-2 inhibitors (SGLT2i), a glucose-lowering drug to improve NAFLD in patients with Type 2 Diabetes.
View Article and Find Full Text PDFUnlabelled: Parental iron replacement is given to patients with severe iron deficiency or intolerance to oral iron. Hypophosphataemia has been reported to occur as a complication of parental iron replacement, and is postulated to be related to the carbohydrate moieties used in the parenteral preparations. Hypophosphataemia is under-diagnosed as symptoms such as fatigue, muscle weakness and poor effort tolerance mimic anaemia.
View Article and Find Full Text PDF